Physiologic assessment of milrinone therapy in severe heart failure patients.

Intravenous milrinone in patients with severe congestive cardiac failure awaiting heart transplantation.

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

Milrinone. A clinical trial in 29 dogs with moderate to severe congestive heart failure.

Preload-dependent hemodynamic effects of milrinone in moderate heart failure.

Effect of milrinone on ventricular arrhythmias in congestive heart failure.

Functional assessment of heart failure patients.

Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.

Hemodynamic effect of dobutamine in patients with severe heart failure.

Cardiac resynchronization therapy in heart failure patients with less severe left ventricular dysfunction.

Xamoterol in severe heart failure.

Vasodilator therapy--a physiologic approach to the treatment of heart failure.

Effects of captopril versus milrinone therapy in modulating the adrenergic nervous system response to exercise in congestive heart failure.

Anemia in severe heart failure patients: does it predict prognosis?

Effects of a twenty-four-hour milrinone infusion in patients with severe heart failure and cardiogenic shock as a function of the hemodynamic initial condition.

Beneficial hemodynamic effects of two weeks' milrinone treatment in conscious rats with heart failure.

$Effectiveness of MitraClip therapy in patients with refractory heart failure.$
Effectiveness of MitraClip therapy in patients with refractory heart failure.

Short-stepping gait in severe heart failure.

Metabolic Therapy in Heart Failure.

Device therapy: CRT effective in elderly patients with heart failure.

Cardiac resynchronisation therapy in patients with chronic heart failure.

Drug therapy of heart failure.

Breathlessness in patients with severe chronic airflow limitation. Physiologic correlations.

Assessment for Exercise Prescription in Heart Failure.

Continuous Intravenous Milrinone Therapy in Pediatric Outpatients.

Suggest Documents

Intravenous milrinone in patients with severe congestive cardiac failure awaiting heart transplantation.

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

Milrinone. A clinical trial in 29 dogs with moderate to severe congestive heart failure.

Preload-dependent hemodynamic effects of milrinone in moderate heart failure.

Effect of milrinone on ventricular arrhythmias in congestive heart failure.

Functional assessment of heart failure patients.

Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.

Hemodynamic effect of dobutamine in patients with severe heart failure.

Cardiac resynchronization therapy in heart failure patients with less severe left ventricular dysfunction.

Xamoterol in severe heart failure.

Vasodilator therapy--a physiologic approach to the treatment of heart failure.

Effects of captopril versus milrinone therapy in modulating the adrenergic nervous system response to exercise in congestive heart failure.

Anemia in severe heart failure patients: does it predict prognosis?

Effects of a twenty-four-hour milrinone infusion in patients with severe heart failure and cardiogenic shock as a function of the hemodynamic initial condition.

Beneficial hemodynamic effects of two weeks' milrinone treatment in conscious rats with heart failure.

Effectiveness of MitraClip therapy in patients with refractory heart failure.

Short-stepping gait in severe heart failure.

Metabolic Therapy in Heart Failure.

Device therapy: CRT effective in elderly patients with heart failure.

Cardiac resynchronisation therapy in patients with chronic heart failure.

Drug therapy of heart failure.

Breathlessness in patients with severe chronic airflow limitation. Physiologic correlations.

Assessment for Exercise Prescription in Heart Failure.

Continuous Intravenous Milrinone Therapy in Pediatric Outpatients.

Physiologic assessment of milrinone therapy in severe heart failure patients.

Recommend Documents

Follow Us